Henning Drechsler, M.D. - Faculty Profile

Biography

Henning Drechsler, M.D., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center, and a member of the Division of Infectious Diseases and Geographic Medicine. He serves as an infectious diseases staff physician at Dallas VA Medical Center.

Originally from Frankfurt, Germany, Dr. Drechsler earned his medical degree at the University of Basel in Switzerland, and completed internal medicine residency training at Emory University in Atlanta. He then completed advanced training through a fellowship in infectious diseases at Washington University in St. Louis.

Certified by the American Board of Internal Medicine in infectious diseases, Dr. Drechsler joined the UT Southwestern faculty in 2006.

Dr. Drechsler's research has resulted in numerous publications in peer-reviewed journals. He is broadly interested in HIV immunopathogenesis and complications of chronic HIV disease. Specifically, the link between clinical outcomes during antiretroviral therapy, immune reconstitution, and metabolic changes regarding cholesterol metabolism with and without lipid-lowering therapy.

Dr. Drechsler is a member of several professional societies, including the American College of Physicians, the Infectious Diseases Society of America, and the International AIDS Society. He is also an Ad Hoc Reviewer for several HIV and infectious disease related journals.

Education

Medical School: University of Basel (1990)

Publications

Choice of antiretroviral therapy has low impact on weight gain: Drechsler H, Ayers C, Oboho I, Enwerem N, Hanna J, Clark C, Kitchell E, Jain M, Luque A, Bedimo R AIDS 2024 Oct 38 1731-1739
Tenofovir disoproxil fumarate withdrawal and cardiovascular risk: Drechsler H, Ayers CR, Bedimo R The Lancet HIV 2023 Jan 10 e8-e9
Serum Cholesterol Variability and Mortality in PLWH On Lipid-Lowering Therapy: Drechsler HJ, Ayers C, Bedimo RJ Open Forum Infectious Diseases 2022 Dec 9
Consistent use of lipid lowering therapy in HIV infection is associated with low mortality: Drechsler H, Ayers C, Cutrell J, Arasaratnam R, Bedimo R BMC Infectious Diseases 2021 Dec 21
Statin use and medically attended acute respiratory illness among influenza vaccine recipients: Cutrell JB, Drechsler H, Bedimo R, Alvarez CA, Mansi IA Vaccine 2019 Oct 37 6707-6713
Brief Report: No Evidence for an Association between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation during Effective ART: Bedimo RJ, Mar H, Bosch RJ, Drechsler H, Cyktor JC, MacAtangay BJ, Lalama C, Rinaldo C, Collier A, Godfrey C, Hogg E, Hensel C, Eron JJ, McMahon DK, Mellors JW, Tebas P, Gandhi RT Journal of Acquired Immune Deficiency Syndromes 2019 Oct 82 E27-E31
Skin disease prevalence study in schoolchildren in rural Côte d'Ivoire: Implications for integration of neglected skin diseases (skin NTDs): Yotsu RR, Kouadio K, Vagamon B, N’guessan K, Akpa AJ, Yao A, Aké J, Abbet Abbet R, Tchamba Agbor Agbor B, Bedimo R, Ishii N, Fuller LC, Hay R, Mitjà O, Drechsler H, Asiedu K PLoS neglected tropical diseases 2018 May 12
Current use of statins reduces risk of HIV rebound on suppressive HAART: Drechsler H, Ayers C, Cutrell J, Maalouf N, Tebas P, Bedimo R PloS one 2017 Mar 12
Mechanisms of bone disease in HIV and hepatitis C virus: Impact of bone turnover, tenofovir exposure, sex steroids and severity of liver disease: Bedimo R, Cutrell J, Zhang S, Drechsler H, Gao A, Brown G, Farukhi I, Castanon R, Tebas P, Maalouf NM AIDS 2016 Feb 30 601-608
The RADAR study: Week 48 safety and efficacy of RAltegravir combined with boosted DARunavir compared to tenofovir/emtricitabine combined with boosted darunavir in antiretroviral-naive patients. Impact on bone health: Bedimo RJ, Drechsler H, Jain M, Cutrell J, Zhang S, Li X, Farukhi I, Castanon R, Tebas P, Maalouf NM PloS one 2014 Aug 9

Professional Associations/Affiliations

American College of Physicians
Infectious Diseases Society of America
International AIDS Society